Assessment of serum alarin levels in patients with type 2 diabetes mellitus

Basit Öğe Kaydı
dc.authorid0000-0002-5323-2257en_US
dc.contributor.authorKılınç, F.
dc.contributor.authorDemircan, F.
dc.contributor.authorGözel, N.
dc.contributor.authorÖnalan, E.
dc.contributor.authorKarataş, A.
dc.contributor.authorPekkolay, Z.
dc.contributor.authorÖzdemir, F. A.
dc.date.accessioned2021-09-14T06:20:14Z
dc.date.available2021-09-14T06:20:14Z
dc.date.issued2020en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıklar Ana Bilim Dalıen_US
dc.descriptionWOS:000597111200007
dc.descriptionPMID: 33029232
dc.description.abstractObjective. We aimed to investigate the potential relationship between plasma alarin levels and type 2 diabetes mellitus (T2DM). Patients and Method. We included 154 participants, divided into four groups in a cross-sectional study design. The first group includes patients with T2DM without complications (n=30), the second group patients with T2DM with microvascular complications (T2DMnoC n=32), the third group patients with T2DM with macrovascular complications, T2DM-MV (n=32) and the last group is the healthy control group (n=60). Results. In our study 94 patients were diabetic; 47 females and 47 males. The control group consists of 60 people, 30 women and 30 men. It was found that these had a significant (p>0.05) variation in serum alarin levels among the T2DM (T2DM-noC=3.1±0.7 ng/mL T2DMmV=2.8±0.4 ng/mL, T2DM-MV= 3.6±0.4 ng/mL) versus control group (15.6±2.6). We failed to find a significant variation of serum alarin levels (p>0.05) between T2DM subgroups. Serum alarin levels were significantly higher among control patients (p<0.05). There was no difference between diabetic sub-groups. Conclusion. We concluded that serum alarin levels in patients with T2DM are lower than in normal people. Further studies are needed to investigate the possible prognostic value of alarin in clinical practice in T2DM.en_US
dc.identifier.citationKılınç, F., Demircan, F. Gözel, N., Önalan, E., Karataş, A., Pekkolay, Z. ve diğerleri. (2020). Assessment of serum alarin levels in patients with type 2 diabetes mellitus. Acta Endocrinologica (Bucharest), 16(2), 165-169.en_US
dc.identifier.doi10.4183/aeb.2020.165
dc.identifier.endpage169en_US
dc.identifier.issn1841-0987
dc.identifier.issn1843-066X
dc.identifier.issue2en_US
dc.identifier.pmid33029232
dc.identifier.scopus2-s2.0-85092464179
dc.identifier.scopusqualityQ4
dc.identifier.startpage165en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535900/pdf/aeb.2020.165.pdf
dc.identifier.urihttps://hdl.handle.net/11468/7539
dc.identifier.volume16en_US
dc.identifier.wosWOS:000597111200007
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorPekkolay, Z.
dc.language.isoenen_US
dc.publisherEditura Acad Romaneen_US
dc.relation.ispartofActa Endocrinologica (Bucharest)
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectType 2 diabetes mellitusen_US
dc.subjectDiabetic complicationsen_US
dc.subjectAlarin levelen_US
dc.titleAssessment of serum alarin levels in patients with type 2 diabetes mellitusen_US
dc.titleAssessment of serum alarin levels in patients with type 2 diabetes mellitus
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Assessment of serum alarin levels in patients with type 2 diabetes mellitus.pdf
Boyut:
248.07 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu